PCYN Stock Overview
Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems in the United States.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Procyon Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.20 |
52 Week High | US$0.31 |
52 Week Low | US$0.15 |
Beta | -0.27 |
1 Month Change | -33.36% |
3 Month Change | 16.82% |
1 Year Change | -5.43% |
3 Year Change | -66.90% |
5 Year Change | -20.89% |
Change since IPO | -86.76% |
Recent News & Updates
Recent updates
Shareholder Returns
PCYN | US Medical Equipment | US Market | |
---|---|---|---|
7D | -33.4% | 2.2% | 0.4% |
1Y | -5.4% | 13.3% | 28.8% |
Return vs Industry: PCYN underperformed the US Medical Equipment industry which returned 12% over the past year.
Return vs Market: PCYN underperformed the US Market which returned 29.5% over the past year.
Price Volatility
PCYN volatility | |
---|---|
PCYN Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 7.7% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.9% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PCYN's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine PCYN's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1987 | 18 | Justice Anderson | https://procyoncorp.com |
Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems in the United States. It provides advanced skin and wound care products, including the hydrogel wound dressing products, post op surgical kits, saline wound washes, care lotions, and barrier lotions to promote healing in wound and problematic skin conditions, as well as hand sanitizer under the AMERIGEL brand name. The company also offers Advantagen, a surgical collagen powder that promotes wound closure and reduces the potential for surgical site infection; and rolled gauze wound care kits.
Procyon Corporation Fundamentals Summary
PCYN fundamental statistics | |
---|---|
Market cap | US$1.61m |
Earnings (TTM) | -US$314.47k |
Revenue (TTM) | US$4.70m |
0.3x
P/S Ratio-5.1x
P/E RatioIs PCYN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PCYN income statement (TTM) | |
---|---|
Revenue | US$4.70m |
Cost of Revenue | US$1.05m |
Gross Profit | US$3.65m |
Other Expenses | US$3.96m |
Earnings | -US$314.47k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.039 |
Gross Margin | 77.60% |
Net Profit Margin | -6.69% |
Debt/Equity Ratio | 0% |
How did PCYN perform over the long term?
See historical performance and comparison